Početna › Mijelodisplastični sindromi
Kliničke studije za Mijelodisplastični sindromi koje traže sudionike u SAD-u
157 studija za Mijelodisplastični sindromi traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX43 studija
- Baldwin Park, CA26 studija
- New York City, NY21 studija
- Seattle, WA21 studija
- Washington, DC20 studija
- Boston, MA19 studija
- Tampa, FL19 studija
- Miami, FL17 studija
- Columbus, OH14 studija
- Durham, NC14 studija
- Chicago, IL13 studija
- Atlanta, GA13 studija
- St. Louis, MO13 studija
- Cleveland, OH11 studija
- Nashville, TN11 studija
- Philadelphia, PA10 studija
- Birmingham, AL10 studija
- Los Angeles, CA10 studija
- Mountain View, CA9 studija
- Pittsburgh, PA9 studija
- Baltimore, MD9 studija
- Winston-Salem, NC9 studija
- Jacksonville, FL9 studija
- The Bronx, NY9 studija
- Portland, OR8 studija
- Buffalo, NY8 studija
- New Haven, CT8 studija
- Milwaukee, WI8 studija
- Minneapolis, MN8 studija
- Salt Lake City, UT8 studija
- Memphis, TN7 studija
- Clifton, NJ7 studija
- Cedar Rapids, IA7 studija
- Edison, NJ7 studija
- Orange, CA7 studija
- Kansas City, MO7 studija
- San Francisco, CA6 studija
- Aurora, CO6 studija
- Rochester, NY6 studija
- Queens, NY6 studija
Po državama
- Alabama10 studija
- Arizona9 studija
- Arkansas4 studija
- Colorado8 studija
- Connecticut10 studija
- Distrikt Columbia4 studija
- Florida31 studija
- Georgia15 studija
- Havaji3 studija
- Idaho4 studija
- Illinois16 studija
- Indiana4 studija
- Iowa7 studija
- Kalifornija41 studija
- Kansas5 studija
- Kentucky5 studija
- Louisiana5 studija
- Maine4 studija
- Maryland23 studija
- Massachusetts21 studija
- Michigan8 studija
- Minnesota13 studija
- Mississippi3 studija
- Missouri15 studija
- Montana3 studija
- Nebraska4 studija
- Nevada3 studija
- New Hampshire5 studija
- New Jersey13 studija
- New Mexico4 studija
- New York38 studija
- North Carolina19 studija
- North Dakota4 studija
- Ohio22 studija
- Oklahoma4 studija
- Oregon10 studija
- Pennsylvania17 studija
- Rhode Island4 studija
- South Carolina7 studija
- Tennessee15 studija
- Texas44 studija
- Utah8 studija
- Vermont3 studija
- Virginia8 studija
- Washington21 studija
- West Virginia4 studija
- Wisconsin11 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
U tijeku regrutacijaFaza 1/2
Od 12 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06303193Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06577441Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06904066Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
U tijeku regrutacijaOpažajna studija
1 Day – 99 Years · Oba spola · Ažurirano 2. lis 2026. · NCT07683104Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06484062Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
U tijeku regrutacijaFaza 1/2
Od 4 do 75 godina · Oba spola · Ažurirano 1. lis 2026. · NCT03173937The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07285044A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
U tijeku regrutacijaFaza 1
Od 12 do 78 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT03802695CHIP/CCUS Natural History Protocol
U tijeku regrutacijaOpažajna studija
Od 18 do 99 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT04102423MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05564390A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06548230Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT03661307Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT05320198Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
U tijeku regrutacijaFaza 2
Od 4 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT01174108Natural History Study of GATA2 Deficiency and Related Disorders
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 do 100 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT01905826A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT07422480Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
U tijeku regrutacijaFaza 1
Od 1 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT03630991CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT04375631Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT04282187Collection of Tissue Samples for Cancer Research
U tijeku regrutacijaOpažajna studija
2 Months · Oba spola · Ažurirano 16. ruj 2026. · NCT00900198Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT06904482Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT03471260Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT03683433A Study of BGB-11417 in Participants With Myeloid Malignancies
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT04771130Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.